(Q34995241)

5 August 2017

1 reference

title

Hormone replacement therapy: optimising the dose and route of administration (English)

1 reference

Hormone Replacement Therapy

5 August 2017

main subject

1 reference

inferred from title

author name string

Valerie Montgomery Rice

series ordinal

1

1 reference

5 August 2017

publication date

1 January 2002

1 reference

5 August 2017

1 reference

5 August 2017

volume

19

1 reference

5 August 2017

issue

11

1 reference

5 August 2017

page(s)

807-818

1 reference

The minimum effective dose of estrogen for prevention of postmenopausal bone loss

5 August 2017

cites work

1 reference

12 December 2020

Progestational and androgenic receptor binding affinities and in vivo activities of norgestimate and other progestins

1 reference

12 December 2020

Efficacy of a continuous estrogen-progestin regimen in the menopausal patient

1 reference

12 December 2020

Effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on plasma lipids and lipoproteins, coagulation factors, and carbohydrate metabolism

1 reference

12 December 2020

Low-dose esterified estrogen therapy: effects on bone, plasma estradiol concentrations, endometrium, and lipid levels. Estratab/Osteoporosis Study Group

1 reference

12 December 2020

Comparison of continuation of postmenopausal hormone replacement therapy: transdermal versus oral estrogen

1 reference

12 December 2020

Prevention of bone loss with tibolone in postmenopausal women: results of two randomized, double-blind, placebo-controlled, dose-finding studies

1 reference

12 December 2020

Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published from 1974-2000.

1 reference

12 December 2020

Rationale for hormone replacement therapy in atherosclerosis prevention

1 reference

12 December 2020

Serum lipid profile improved by ultra-low doses of 17 beta-estradiol in elderly women

1 reference

12 December 2020

Long-term effect of transdermal hormonal therapy on aspects of quality of life in postmenopausal women

1 reference

12 December 2020

Uterine bleeding in postmenopausal women on continuous therapy with estradiol and norethindrone acetate. Endometrium Study Group

1 reference

12 December 2020

Effects of 2 years of hormone replacement upon bone mass, serum lipids and lipoproteins

1 reference

12 December 2020

Effect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in early postmenopausal women

1 reference

12 December 2020

The effects of six months of treatment with a low-dose of conjugated oestrogens in menopausal women.

1 reference

12 December 2020

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

1 reference

12 December 2020

Endometrial effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate

1 reference

12 December 2020

Do estrogens effectively prevent osteoporosis-related fractures? The Group for the Respect of Ethics and Excellence in Science

1 reference

12 December 2020

Efficacy and tolerability of a low-dose of Oesclim (25 mcg daily) in the management of symptomatic menopausal women: a French open-label study.

1 reference

12 December 2020

[Transdermal estrogen treatment. A placebo controlled study]

1 reference

12 December 2020

Effects on serum lipid profiles of continuous 17beta-estradiol, intermittent norgestimate regimens versus continuous combined 17beta-estradiol/norethisterone acetate hormone replacement therapy

1 reference

12 December 2020

Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate

1 reference

12 December 2020

Efficacy and local tolerance of a low-dose, 7-day matrix estradiol transdermal system in the treatment of menopausal vasomotor symptoms

1 reference

12 December 2020

Failure of estrogen plus progestin therapy for prevention

1 reference

12 December 2020

Acceptability and patterns of endometrial bleeding in estradiol-based HRT regimens: a comparative study of cyclical sequential combinations of trimegestone or norethisterone acetate

1 reference

12 December 2020

A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density

1 reference

12 December 2020

Symptom relief and side effects of postmenopausal hormones: results from the Postmenopausal Estrogen/Progestin Interventions Trial

1 reference

12 December 2020

The effect of low-dose continuous estrogen and progesterone therapy with calcium and vitamin D on bone in elderly women. A randomized, controlled trial

1 reference

12 December 2020

Timing of estrogen replacement therapy for optimal osteoporosis prevention.

1 reference

12 December 2020

Low-dosage micronized 17 beta-estradiol prevents bone loss in postmenopausal women

1 reference

12 December 2020

Livial: a review of clinical studies

1 reference

12 December 2020

Prevention of postmenopausal bone loss with minimal uterine bleeding using low dose continuous estrogen/progestin therapy: a 2-year prospective study

1 reference

12 December 2020

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

1 reference

12 December 2020

Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial

1 reference

12 December 2020

Efficacy and safety of a constant-estrogen, pulsed-progestin regimen in hormone replacement therapy

1 reference

12 December 2020

Bone mineral density response to estrogen replacement in frail elderly women: a randomized controlled trial

1 reference

12 December 2020

Prevention of postmenopausal osteoporosis with oestrogen replacement therapy and associated compounds: update on clinical trials since 1995.

1 reference

12 December 2020

Hormone therapy and in-hospital survival after myocardial infarction in postmenopausal women

1 reference

12 December 2020

Effect of a unique constant-estrogen, pulsed-progestin hormone replacement therapy containing 17beta-estradiol and norgestimate on endometrial histology

1 reference

12 December 2020

Long-term effects of percutaneous estrogens and oral progesterone on serum lipoproteins in postmenopausal women

1 reference

12 December 2020

Quantitative Computed Tomography of Vertebral Spongiosa: A Sensitive Method for Detecting Early Bone Loss After Oophorectomy

1 reference

12 December 2020

Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys. Lack of an effect of added progesterone

1 reference

12 December 2020

The effects of estrone (Ogen) on spinal bone density of postmenopausal women

1 reference

12 December 2020

Hormone replacement therapy: effect of progestin dose and time since menopause on endometrial bleeding

1 reference

12 December 2020

Initial 17beta-estradiol dose for treating vasomotor symptoms

1 reference

12 December 2020

A meta-analysis of hormone replacement therapy for fracture prevention

1 reference

12 December 2020

A novel intermittent regimen of norgestimate to preserve the beneficial effects of 17beta-estradiol on lipid and lipoprotein profiles

1 reference

12 December 2020

Bleeding patterns in postmenopausal women taking continuous combined or sequential regimens of conjugated estrogens with medroxyprogesterone acetate. Menopause Study Group

1 reference

12 December 2020

Effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on endometrial bleeding

1 reference

12 December 2020

Postmenopausal hormone use and secondary prevention of coronary events in the nurses' health study. a prospective, observational study

1 reference

12 December 2020

A prospective population-based study of menopausal symptoms.

1 reference

12 December 2020

Quality of life during sequential hormone replacement therapy -- a placebo-controlled study

1 reference

12 December 2020

Effects of estrogen replacement on the progression of coronary-artery atherosclerosis

1 reference

12 December 2020

Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial

1 reference

12 December 2020

Efficacy of sequential hormone replacement therapy in the treatment of hypercholesterolaemia among postmenopausal women

1 reference

12 December 2020

Hormone replacement therapy and prevention of nonvertebral fractures: a meta-analysis of randomized trials

1 reference

12 December 2020

Bone loss in elderly women prevented by ultralow doses of parenteral 17β-estradiol

1 reference

12 December 2020

Low-dosage esterified estrogens opposed by progestin at 6-month intervals

1 reference

12 December 2020

A 12-week clinical trial determining the efficacy of synthetic conjugated estrogens, A (SCE), in the treatment of vasomotor symptoms in menopausal women

1 reference

12 December 2020

Postmenopausal bone loss is prevented by treatment with low-dosage estrogen with calcium

1 reference

12 December 2020

Efficacy and acceptability of intranasal 17 beta-oestradiol for menopausal symptoms: randomised dose-response study. Aerodiol Study Group

1 reference

12 December 2020

Personal perspective on low-dosage estrogen therapy for postmenopausal women

1 reference

12 December 2020

The comparative effect on bone density, endometrium, and lipids of continuous hormones as replacement therapy (CHART study). A randomized controlled trial.

1 reference

12 December 2020

Lipoproteins during oral and cutaneous administration of oestradiol-17 beta to menopausal women

1 reference

12 December 2020

A systematic review of the skeletal effects of estrogen therapy in postmenopausal women. II. An assessment of treatment effects

1 reference

12 December 2020

10.2165/00002512-200219110-00001

Identifiers

DOI

1 reference

Dimensions Publication ID

5 August 2017

1048156388

0 references

1 reference